Literature DB >> 20972331

Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.

Kehmia Titanji1, Vijayakumar Velu, Lakshmi Chennareddi, Matam Vijay-Kumar, Andrew T Gewirtz, Gordon J Freeman, Rama R Amara.   

Abstract

Rapid progression to AIDS is a significant problem, especially in developing countries, where the majority of HIV-infected individuals reside. As rapid disease progression is also frequently observed in SIV-infected macaques, they represent a valuable tool to investigate the pathogenesis of this condition in humans. Here, we have shown that pathogenic SIV infection in rhesus macaques resulted in a rapid depletion (as early as week 2) of activated memory B (CD21-CD27+; mBAct) cells that was strongly associated with rapid disease progression. This depletion was progressive and sustained in rapid progressors, but less severe and transient in typical progressors. Because of the rapid and sustained depletion of mBAct cells, rapid progressors failed to develop SIV-specific Ab responses, showed a decline in non-SIV-specific Ab titers, and succumbed faster to intestinal bacterial infections. Depletion of mBAct cells was strongly associated with preferential depletion of mBAct cells expressing programmed death-1 (PD-1), and in vitro blockade of PD-1 improved their survival. Furthermore, in vivo PD-1 blockade in SIV-infected macaques enhanced Ab responses to non-SIV as well as SIV Ags. Our results identify depletion of mBAct cells as a very early predictor of rapid disease progression in pathogenic SIV infection and suggest an important role for the PD-1 pathway in depletion of mBAct cells and impaired humoral immune responses in SIV-infected macaques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972331      PMCID: PMC2964982          DOI: 10.1172/JCI43271

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  Concurrent infections and HIV pathogenesis.

Authors:  Z Bentwich; G Maartens; D Torten; A A Lal; R B Lal
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

2.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state.

Authors:  A Bar-Or; E M Oliveira; D E Anderson; J I Krieger; M Duddy; K C O'Connor; D A Hafler
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 4.  The role of motility as a virulence factor in bacteria.

Authors:  Christine Josenhans; Sebastian Suerbaum
Journal:  Int J Med Microbiol       Date:  2002-03       Impact factor: 3.473

5.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.

Authors:  Daria Trabattoni; Marina Saresella; Mara Biasin; Adriano Boasso; Luca Piacentini; Pasquale Ferrante; Haidong Dong; Renato Maserati; Gene M Shearer; Lieping Chen; Mario Clerici
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

6.  Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study.

Authors:  Dilys Morgan; Cedric Mahe; Billy Mayanja; James A G Whitworth
Journal:  BMJ       Date:  2002-01-26

7.  Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.

Authors:  Sanjay M Mehendale; Robert C Bollinger; Smita S Kulkarni; Rebecca Y Stallings; Ronald S Brookmeyer; Sangita V Kulkarni; Anand D Divekar; Raman R Gangakhedkar; Smita N Joshi; Arun R Risbud; Madhuri A Thakar; Bharati A Mahajan; Varsha A Kale; Manisha V Ghate; Deepak A Gadkari; Thomas C Quinn; Ramesh S Paranjape
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-01       Impact factor: 2.205

8.  Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.

Authors:  Rama Rao Amara; James M Smith; Silvija I Staprans; David C Montefiori; Francois Villinger; John D Altman; Shawn P O'Neil; Natalia L Kozyr; Yan Xu; Linda S Wyatt; Patricia L Earl; James G Herndon; Janet M McNicholl; Harold M McClure; Bernard Moss; Harriet L Robinson
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

9.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

10.  Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques.

Authors:  Rosemarie D Mason; Robert De Rose; Nabila Seddiki; Anthony D Kelleher; Stephen J Kent
Journal:  Virology       Date:  2008-10-02       Impact factor: 3.616

View more
  72 in total

1.  Rapid HIV Progression Is Associated with Extensive Ongoing Somatic Hypermutation.

Authors:  Ben S Wendel; Yajing Fu; Chenfeng He; Stefany M Hernandez; Mingjuan Qu; Zining Zhang; Yongjun Jiang; Xiaoxu Han; Junjie Xu; Haibo Ding; Ning Jiang; Hong Shang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors.

Authors:  Lela Kardava; Susan Moir; Wei Wang; Jason Ho; Clarisa M Buckner; Jacqueline G Posada; Marie A O'Shea; Gregg Roby; Jenny Chen; Hae Won Sohn; Tae-Wook Chun; Susan K Pierce; Anthony S Fauci
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

3.  Key Concepts in the Early Immunology of HIV-1 Infection.

Authors:  Basile Siewe; Alan Landay
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

4.  Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens.

Authors:  Karen M Haas
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

5.  New therapy to revert dysfunctional antibody responses during HIV-1 infection.

Authors:  Francesca Chiodi
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

6.  Improved flow-based method for HIV/SIV envelope-specific memory B-cell evaluation in rhesus macaques.

Authors:  Venkatramanan Mohanram; Thorsten Demberg; Iskra Tuero; Diego Vargas-Inchaustegui; George N Pavlakis; Barbara K Felber; Marjorie Robert-Guroff
Journal:  J Immunol Methods       Date:  2014-06-19       Impact factor: 2.303

7.  Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection.

Authors:  Jingjing Yan; Shuye Zhang; Jun Sun; Jianqing Xu; Xiaoyan Zhang
Journal:  Front Med       Date:  2017-11-27       Impact factor: 4.592

Review 8.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

9.  Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model.

Authors:  Thorsten Demberg; Venkatramanan Mohanram; David Venzon; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

10.  Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Authors:  Rama D Yammani; Karen M Haas
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.